Cargando…

Thrombolytic therapy for critical limb ischemia in a Jehovah's Witness with severe anemia

A patient's refusal to receive blood products can pose both clinical and ethical challenges to the surgeon. In this report, we review the case of a Jehovah's Witness presenting with critical lower limb ischemia and severe anemia for whom the decision of whether to perform thrombolytic ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Kauffman, Jeremy D., Watson, T. Joseph, Campbell, Joseph J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764890/
https://www.ncbi.nlm.nih.gov/pubmed/29349406
http://dx.doi.org/10.1016/j.jvscit.2017.05.003
_version_ 1783292113864097792
author Kauffman, Jeremy D.
Watson, T. Joseph
Campbell, Joseph J.
author_facet Kauffman, Jeremy D.
Watson, T. Joseph
Campbell, Joseph J.
author_sort Kauffman, Jeremy D.
collection PubMed
description A patient's refusal to receive blood products can pose both clinical and ethical challenges to the surgeon. In this report, we review the case of a Jehovah's Witness presenting with critical lower limb ischemia and severe anemia for whom the decision of whether to perform thrombolytic therapy was complicated by his refusal to accept blood products. The case demonstrates that thrombolytic therapy can produce favorable results in severely anemic patients even when transfusion is not an option. We conclude that offering thrombolytic therapy in this context is a reasonable therapeutic option from both a clinical and ethical perspective.
format Online
Article
Text
id pubmed-5764890
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-57648902018-01-18 Thrombolytic therapy for critical limb ischemia in a Jehovah's Witness with severe anemia Kauffman, Jeremy D. Watson, T. Joseph Campbell, Joseph J. J Vasc Surg Cases Innov Tech Complex aortic aneurysm A patient's refusal to receive blood products can pose both clinical and ethical challenges to the surgeon. In this report, we review the case of a Jehovah's Witness presenting with critical lower limb ischemia and severe anemia for whom the decision of whether to perform thrombolytic therapy was complicated by his refusal to accept blood products. The case demonstrates that thrombolytic therapy can produce favorable results in severely anemic patients even when transfusion is not an option. We conclude that offering thrombolytic therapy in this context is a reasonable therapeutic option from both a clinical and ethical perspective. Elsevier 2017-07-18 /pmc/articles/PMC5764890/ /pubmed/29349406 http://dx.doi.org/10.1016/j.jvscit.2017.05.003 Text en © 2017 The Author(s) http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Complex aortic aneurysm
Kauffman, Jeremy D.
Watson, T. Joseph
Campbell, Joseph J.
Thrombolytic therapy for critical limb ischemia in a Jehovah's Witness with severe anemia
title Thrombolytic therapy for critical limb ischemia in a Jehovah's Witness with severe anemia
title_full Thrombolytic therapy for critical limb ischemia in a Jehovah's Witness with severe anemia
title_fullStr Thrombolytic therapy for critical limb ischemia in a Jehovah's Witness with severe anemia
title_full_unstemmed Thrombolytic therapy for critical limb ischemia in a Jehovah's Witness with severe anemia
title_short Thrombolytic therapy for critical limb ischemia in a Jehovah's Witness with severe anemia
title_sort thrombolytic therapy for critical limb ischemia in a jehovah's witness with severe anemia
topic Complex aortic aneurysm
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5764890/
https://www.ncbi.nlm.nih.gov/pubmed/29349406
http://dx.doi.org/10.1016/j.jvscit.2017.05.003
work_keys_str_mv AT kauffmanjeremyd thrombolytictherapyforcriticallimbischemiainajehovahswitnesswithsevereanemia
AT watsontjoseph thrombolytictherapyforcriticallimbischemiainajehovahswitnesswithsevereanemia
AT campbelljosephj thrombolytictherapyforcriticallimbischemiainajehovahswitnesswithsevereanemia